1-13 of 13
Thomas Meyer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6274: Integrated multi-omics revealed the involvement of MYC and mTOR pathways in radiation resistance of adrenocortical cancer

Bhavishya Ramamoorthy, Prachi Mishra, Myriem Boufraqech, Nicholas Michael, Margaret Cam, Richard Finney, Thomas Meyer, Ronald Holewinski, Thorkell Andresson, Madeline Wong, Steven Shema, Desiree Tillo, Naris Nilubol
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6274.
https://doi.org/10.1158/1538-7445.AM2024-6274
Published: 22 March 2024
View articletitled, Abstract 6274: Integrated multi-omics revealed the involvement of MYC and mTOR pathways in radiation resistance of adrenocortical cancer
Journal Articles

Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancer

Mee Young Chang, Janette Boulden, Jessica Katz, Liwei Wang, Thomas Meyer, Alejandro Soler, Alexander Muller, George Prendergast
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 2778.
Published: 01 May 2008
View articletitled, Bin1 ablation increases susceptibility to cancer during aging, particularly lung cancer
Journal Articles

Extended kinase profiling of the Bcr-Abl inhibitor nilotinib

Paul Manley, Josef Bruggen, Doriano Fabbro, Georg Martiny-Baron, Thomas Meyer
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3249.
Published: 01 May 2007
View articletitled, Extended kinase profiling of the Bcr-Abl inhibitor nilotinib
Journal Articles

siRNA-mediated inhibition of insulin-lke growth factor binding protein 1 (IGFBP-1) in tumor cells results in decreased proliferation and increased apoptosis: A potential therapeutic option for metastatic disease

Bernhard Gentner, Franz Roedel, Axel Wein, Stefan Schultze-Mosgau, Roland S. Croner, Thomas Meyer, Thomas Kirchner, Werner Hohenberger, Eckhart G. Hahn, Wolfgang M. Brueckl
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 552.
Published: 01 May 2005
View articletitled, siRNA-mediated inhibition of insulin-lke growth factor binding protein 1 (IGFBP-1) in tumor cells results in decreased proliferation and increased apoptosis: A potential therapeutic option for metastatic disease
Journal Articles

Characterization of the effects of a small molecular weight inhibitor on IGF-I induced angiogenesis

Christian Schnell, Georg Martiny-Baron, Jeanette Wood, Francesco Hofmann, Hansgeorg Capraro, Doriano Fabbro, Pascal Furet, Carlos Garcia-Echeverria, Jurgen Mestan, Thomas Meyer, Mark A. Pearson
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 358.
Published: 01 May 2005
View articletitled, Characterization of the effects of a small molecular weight inhibitor on IGF-I induced angiogenesis
Journal Articles

Characterization of a novel, small molecular weight IGFI-R inhibitor

Konstantina Grosios, Francesco Hofmann, Josef Brueggen, Hansgeorg Capraro, Robert Cozens, Doriano Fabbro, Pascal Furet, Carlos Garcia-Echeverria, Georg Martiny-Baron, Juergen Mestan, Thomas Meyer, Mark A. Pearson
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1406.
Published: 01 May 2005
View articletitled, Characterization of a novel, small molecular weight IGFI-R inhibitor
Journal Articles

AEE788: A Dual Family Epidermal Growth Factor Receptor/ErbB2 and Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor with Antitumor and Antiangiogenic Activity

Peter Traxler, Peter R. Allegrini, Ralf Brandt, Josef Brueggen, Robert Cozens, Doriano Fabbro, Konstantina Grosios, Heidi A. Lane, Paul McSheehy, Jürgen Mestan, Thomas Meyer, Careen Tang, Markus Wartmann, Jeanette Wood, Giorgio Caravatti
Journal: Cancer Research
Cancer Res (2004) 64 (14): 4931–4941.
https://doi.org/10.1158/0008-5472.CAN-03-3681
Published: 15 July 2004
View articletitled, AEE788: A Dual Family Epidermal Growth Factor Receptor/ErbB2 and Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor with Antitumor and Antiangiogenic Activity
Open the PDF for AEE788: A Dual Family Epidermal Growth Factor Receptor/ErbB2 and Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor with Antitumor and Antiangiogenic Activity in another window
Journal Articles

Identification and characterization of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with AML.

Thomas Kindler, Frank Breitenbuecher, Stefan Kasper, Kerstin Kunz, Birgit Carius, Thomas Meyer, Harald Gschaidmeier, Christoph Huber, Thomas Fischer
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 852.
Published: 01 April 2004
View articletitled, Identification and characterization of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with AML.
Journal Articles

An ELISA for PDGFR phosphorylation: Comparison of effects of STI571 on cellular Bcr-Abl, c-Kit and PDGFR-β protein kinases

Paul W. Manley, Juergen Mestan, Thomas Meyer, Doriano Fabbro
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 345–346.
Published: 01 April 2004
View articletitled, An ELISA for PDGFR phosphorylation: Comparison of effects of STI571 on cellular Bcr-Abl, c-Kit and PDGFR-β protein kinases
Journal Articles

Analysis of the Major Histocompatibility Complex Class I Antigen Presentation Machinery in Normal and Malignant Renal Cells: Evidence for Deficiencies Associated with Transformation and Progression

Barbara Seliger, Alexandra Höhne, Alexander Knuth, Helga Bernhard, Thomas Meyer, Robert Tampe, Frank Momburg, Christoph Huber
Journal: Cancer Research
Cancer Res (1996) 56 (8): 1756–1760.
Published: 01 April 1996
View articletitled, Analysis of the Major Histocompatibility Complex Class I Antigen Presentation Machinery in Normal and Malignant Renal Cells: Evidence for Deficiencies Associated with Transformation and Progression
Open the PDF for Analysis of the Major Histocompatibility Complex Class I Antigen Presentation Machinery in Normal and Malignant Renal Cells: Evidence for Deficiencies Associated with Transformation and Progression in another window
Journal Articles

Inhibition of the Abl Protein-Tyrosine Kinase in Vitro and in Vivo by a 2-Phenylaminopyrimidine Derivative

Elisabeth Buchdunger, Jürg Zimmermann, Helmut Mett, Thomas Meyer, Marcel Müller, Brian J. Druker, Nicholas B. Lydon
Journal: Cancer Research
Cancer Res (1996) 56 (1): 100–104.
Published: 01 January 1996
View articletitled, Inhibition of the Abl Protein-Tyrosine Kinase in Vitro and in Vivo by a 2-Phenylaminopyrimidine Derivative
Open the PDF for Inhibition of the Abl Protein-Tyrosine Kinase in Vitro and in Vivo by a 2-Phenylaminopyrimidine Derivative in another window
Journal Articles

Benzopyranones and Benzothiopyranones: A Class of Tyrosine Protein Kinase Inhibitors with Selectivity for the v-abl Kinase

Johanna F. Geissler, Johannes L. Roesel, Thomas Meyer, Uwe P. Trinks, Peter Traxler, Nicholas B. Lydon
Journal: Cancer Research
Cancer Res (1992) 52 (16): 4492–4498.
Published: 01 August 1992
View articletitled, Benzopyranones and Benzothiopyranones: A Class of Tyrosine Protein Kinase Inhibitors with Selectivity for the v-abl Kinase
Open the PDF for Benzopyranones and Benzothiopyranones: A Class of Tyrosine Protein Kinase Inhibitors with Selectivity for the v-abl Kinase in another window
Journal Articles

Enhancement of N-Methyl-N′-nitro-N-nitrosoguanidine-induced DNA Amplification in a Simian Virus 40-transformed Chinese Hamster Cell Line by 3-Aminobenzamide

Alexander Bürkle, Thomas Meyer, Helmuth Hilz, Harald zur Hausen
Journal: Cancer Research
Cancer Res (1987) 47 (14): 3632–3636.
Published: 01 July 1987
View articletitled, Enhancement of N-Methyl-N′-nitro-N-nitrosoguanidine-induced DNA Amplification in a Simian Virus 40-transformed Chinese Hamster Cell Line by 3-Aminobenzamide
Open the PDF for Enhancement of N-Methyl-N′-nitro-N-nitrosoguanidine-induced DNA Amplification in a Simian Virus 40-transformed Chinese Hamster Cell Line by 3-Aminobenzamide in another window